Endo Pharmaceuticals Drives Growth in Pain Management with Acquisition of Penwest
Heather Cartwright
Abstract
Endo Pharmaceuticals has acquired its long-term partner Penwest Pharmaceuticals, in a deal valued at US$168 M that will enable it to drive growth in pain management.
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.